Cargando…
Profiling of Ecstasy Tablets Seized in Iran
In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828921/ https://www.ncbi.nlm.nih.gov/pubmed/24250345 |
_version_ | 1782291309981073408 |
---|---|
author | Khajeamiri, Ali Reza Kobarfard, Farzad Ahmadkhaniha, Reza Mostashari, Gelareh |
author_facet | Khajeamiri, Ali Reza Kobarfard, Farzad Ahmadkhaniha, Reza Mostashari, Gelareh |
author_sort | Khajeamiri, Ali Reza |
collection | PubMed |
description | In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these tablets, color tests (Marquis test, Simon’s test, Chen’s test and Gallic acid test), Thin Layer Chromatography (TLC), anion test, residual solvents, Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were carried out on the tablets. The range of tablets weight was 96–308 mg and the range of 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride content in these tablets was 60–180 mg. No good correlation was found between the tablets weight and their MDMA contents. All of the tablets containing MDMA had this compound in hydrochloride form. Ketamine, phenmetrazine and ephedrine (or pseudoephedrine) were found in some of the tablets along with MDMA. No MDMA was found in 20% of the tablets. Some of these tablets contained compounds such as caffeine or tramadol as their active ingredient. |
format | Online Article Text |
id | pubmed-3828921 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Shaheed Beheshti University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-38289212013-11-18 Profiling of Ecstasy Tablets Seized in Iran Khajeamiri, Ali Reza Kobarfard, Farzad Ahmadkhaniha, Reza Mostashari, Gelareh Iran J Pharm Res Original Article In this study 50 samples of ecstasy tablets seized in Iran during the period of 2007 through 2008 were examined and their physical characteristics (appearance, marking, scored/not scored, color, weight, diameter, thickness) were determined. In order to determine the chemical characteristics of these tablets, color tests (Marquis test, Simon’s test, Chen’s test and Gallic acid test), Thin Layer Chromatography (TLC), anion test, residual solvents, Gas Chromatography-Mass Spectrometry (GC-MS) and Liquid Chromatography-Mass Spectrometry (LC-MS) were carried out on the tablets. The range of tablets weight was 96–308 mg and the range of 3,4-methylenedioxymethamphetamine (MDMA) hydrochloride content in these tablets was 60–180 mg. No good correlation was found between the tablets weight and their MDMA contents. All of the tablets containing MDMA had this compound in hydrochloride form. Ketamine, phenmetrazine and ephedrine (or pseudoephedrine) were found in some of the tablets along with MDMA. No MDMA was found in 20% of the tablets. Some of these tablets contained compounds such as caffeine or tramadol as their active ingredient. Shaheed Beheshti University of Medical Sciences 2011 /pmc/articles/PMC3828921/ /pubmed/24250345 Text en © 2011 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Khajeamiri, Ali Reza Kobarfard, Farzad Ahmadkhaniha, Reza Mostashari, Gelareh Profiling of Ecstasy Tablets Seized in Iran |
title | Profiling of Ecstasy Tablets Seized in Iran |
title_full | Profiling of Ecstasy Tablets Seized in Iran |
title_fullStr | Profiling of Ecstasy Tablets Seized in Iran |
title_full_unstemmed | Profiling of Ecstasy Tablets Seized in Iran |
title_short | Profiling of Ecstasy Tablets Seized in Iran |
title_sort | profiling of ecstasy tablets seized in iran |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828921/ https://www.ncbi.nlm.nih.gov/pubmed/24250345 |
work_keys_str_mv | AT khajeamirialireza profilingofecstasytabletsseizediniran AT kobarfardfarzad profilingofecstasytabletsseizediniran AT ahmadkhanihareza profilingofecstasytabletsseizediniran AT mostasharigelareh profilingofecstasytabletsseizediniran |